Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infections | D007239 | EFO_0000544 | — | — | — | 1 | — | — | 1 |
Hepatitis c | D006526 | — | B19.2 | — | — | 1 | — | — | 1 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | 1 | — | — | 1 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | — | — | 1 | — | — | 1 |
Communicable diseases | D003141 | — | — | — | — | 1 | — | — | 1 |
Hepatitis | D006505 | — | K75.9 | — | — | 1 | — | — | 1 |
Chronic hepatitis | D006521 | — | K73.9 | — | — | 1 | — | — | 1 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | — | 1 | — | — | 1 |
Drug common name | Tozadenant |
INN | tozadenant |
Description | Tozadenant is a member of benzothiazoles. |
Classification | Small molecule |
Drug class | adenosine receptor antagonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12 |
PDB | — |
CAS-ID | 870070-55-6 |
RxCUI | — |
ChEMBL ID | CHEMBL2105747 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB12203 |
UNII ID | D9K857J81I (ChemIDplus, GSRS) |